BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2195358)

  • 1. [Serine protease inhibitors (serpins); regulators of coagulation and inflammation reactions with therapeutic potential].
    Hack CE; Abbink JJ; Nuijens JH
    Ned Tijdschr Geneeskd; 1990 May; 134(21):1035-9. PubMed ID: 2195358
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutrophil serine proteases: potential key regulators of cell signalling during inflammation.
    Wiedow O; Meyer-Hoffert U
    J Intern Med; 2005 Apr; 257(4):319-28. PubMed ID: 15788001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of elastase inhibitors in emphysema treatment.
    Eriksson S
    Eur Respir J; 1991 Oct; 4(9):1041-3. PubMed ID: 1684550
    [No Abstract]   [Full Text] [Related]  

  • 4. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
    Whisstock J; Lesk AM; Carrell R
    Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of a therapeutic agent for the treatment of chronic obstructive pulmonary disease in smokers.
    Turino GM; Davies P; Dunlap R; Krell RD; Maycock AL; Rennard S; Stockley RA
    Ann N Y Acad Sci; 1991 Dec; 624 Suppl():23-30. PubMed ID: 1686162
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion.
    Shamamian P; Pocock BJ; Schwartz JD; Monea S; Chuang N; Whiting D; Marcus SG; Galloway AC; Mignatti P
    Surgery; 2000 Feb; 127(2):142-7. PubMed ID: 10686978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Lys335 in the metastability and function of inhibitory serpins.
    Im H; Yu MH
    Protein Sci; 2000 May; 9(5):934-41. PubMed ID: 10850803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allergy-like symptom caused by mite-protease].
    Matsushima A; Inada Y; Maeda H
    Tanpakushitsu Kakusan Koso; 1993 Dec; 38(16):2734-9. PubMed ID: 8278613
    [No Abstract]   [Full Text] [Related]  

  • 9. Engineering thermostability in serine protease inhibitors.
    Im H; Ryu MJ; Yu MH
    Protein Eng Des Sel; 2004 Apr; 17(4):325-31. PubMed ID: 15126675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viscous drag as the source of active site perturbation during protease translocation: insights into how inhibitory processes are controlled by serpin metastability.
    Shin JS; Yu MH
    J Mol Biol; 2006 Jun; 359(2):378-89. PubMed ID: 16626735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.
    Duranton J; Adam C; Bieth JG
    Biochemistry; 1998 Aug; 37(32):11239-45. PubMed ID: 9698370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic mechanism of protease inhibition by alpha1-antitrypsin.
    Kang UB; Baek JH; Ryu SH; Kim J; Yu MH; Lee C
    Biochem Biophys Res Commun; 2004 Oct; 323(2):409-15. PubMed ID: 15369767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human leukocyte elastase].
    Bieth JG
    Pathol Biol (Paris); 1988 Nov; 36(9):1108-11. PubMed ID: 3065702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serine protease inhibitor family from Ascaris suum: chemical determination of the five disulfide bridges.
    Bernard VD; Peanasky RJ
    Arch Biochem Biophys; 1993 Jun; 303(2):367-76. PubMed ID: 8512322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin-(dithiol-)linked inactivation of elastase.
    del Val G; Hagie FE; Buchanan BB
    Mol Immunol; 2002 Feb; 38(10):759-63. PubMed ID: 11841835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-DNase II activation by the 24 kDa apoptotic protease (AP24) in TNFalpha-induced apoptosis.
    Altairac S; Wright SC; Courtois Y; Torriglia A
    Cell Death Differ; 2003 Sep; 10(9):1109-11. PubMed ID: 12934085
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis.
    Brown MA; Scuderi P; McIntosh JC; Pfeffer K; Parsons P
    Am Rev Respir Dis; 1990 Oct; 142(4):984-5. PubMed ID: 2221602
    [No Abstract]   [Full Text] [Related]  

  • 18. Serendipitous discovery of an unexpected rearrangement leads to two new classes of potential protease inhibitors.
    Zhong J; Lai Z; Groutas CS; Wong T; Gan X; Alliston KR; Eichhorn D; Hoidal JR; Groutas WC
    Bioorg Med Chem; 2004 Dec; 12(23):6249-54. PubMed ID: 15519167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular proteases and their inhibitors in genetic diseases of the central nervous system.
    Molinari F; Meskanaite V; Munnich A; Sonderegger P; Colleaux L
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R195-200. PubMed ID: 12925575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the human serine protease inhibitor alpha-1-antitrypsin with Cryptosporidium parvum.
    Forney JR; Yang S; Healey MC
    J Parasitol; 1996 Jun; 82(3):496-502. PubMed ID: 8636860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.